Senior Specialist, Quality Assurance Operations
enGene (NASDAQ: ENGN) is a late-stage biotechnology company mainstreaming genetic medicines through the delivery... are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene's PROPRIETARY, Dually Derivatized Oligochitosan (DDX...
Lugar: Boston, MA | 10/01/2026 20:01:29 PM | Salario: S/. $115000 - 135000 per year | Empresa: enGene